Back

Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after non-cardiac surgery

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Heart failure management: cardiac resynchronisation therapy and guideline-directed medical therapy synergy Pharmacotherapy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Koray Durak

Cardiovascular Research Institute Basel, Basel (Switzerland)

6 More presentations in this session

Presentation thumbnail
The shorter the better? clinical outcomes of CRT-P/D-patients with a focus on stimulated QRS duration.
Doctor R. Larbig (Moenchengladbach, DE)
Abstract Slides Video
Presentation thumbnail
Medication non-adherence assessed using liquid chromatography tandem mass spectrometry in ambulatory patients with heart failure referred for device therapy assessment
Doctor S. Sze (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Optimisation of guideline-directed medical therapy following cardiac resynchronization therapy in patients with heart failure
Doctor M. Montella (Monza, IT)
Abstract Slides Video
Presentation thumbnail
Patterns of medication use among patients hospitalized for heart failure
Ms S. Matseyko (DE)
Abstract Slides Video
Presentation thumbnail
Hemodynamic changes in response to SGLT2 inhibitor treatment in ICD and CRT patients: insights from HeartLogic sensor data
Doctor F. Fussing (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure management: cardiac resynchronisation therapy and guideline-directed medical therapy synergy

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of SGLT2i in the perioperative care of cardiac surgery: a systematic review and meta-analysis of randomised controlled trials
30 August 2026
thumbnail
Congress Presentation
Guideline adherence to statin therapy and association with major adverse cardiac events in high-risk patients following major noncardiac surgery
27 August 2023
thumbnail
Congress Presentation
Highlights from the STOP-or-NOT Trial
31 August 2024
thumbnail
Congress Presentation
Cardiovascular diseases and type 2 diabetes mellitus: high heart failure risk and low rate contraindications to SGLT2i
13 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources